ongitudinal documentation of pharmacovigilance and pharmacoepidemiology
- Conditions
- Patients using drugs
- Registration Number
- DRKS00011200
- Lead Sponsor
- Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Drug use
Exclusion Criteria
Suspected misdocumentation
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility of data collection (i.e., check for sufficiently complete documentation of all patients seen during the ward rounds)
- Secondary Outcome Measures
Name Time Method Prescription rate, grouped for on-label and off-label and palliative or curative treatment<br>Rate of known DDI in prescriptions<br>Rate of inadequate dosing in renal disease<br>Assessment of clinical significance of the DDI findings<br>Subjective efficacy of medication<br>Mean treatment duration<br>Rate of suspected ADR<br>Documentation of efficacy/safety of other measures not regulated by German drug law<br>Documentation of time spent for clinical-pharmacological rounds<br>